Zotefoams PLC Notification Of Transactions Of Directors/PDMRs

RNS Number : 3172A

Zotefoams PLC

14 August 2024

 

Zotefoams plc

(the 'Company')

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMR

14 August 2024 - The Company has received notification from the Share Incentive Plan ('SIP') Trustee (Link Market Services Trustees Limited) that on 12 August 2024 the following Director and Person Discharging Managerial Responsibilities (PDMR) became beneficially interested in the number of ordinary shares of 5 pence in the Company under the Zotefoams Share Incentive Plan as detailed below. The shares were purchased at a price of £4.8878 per share.

 

The table sets out the number of shares purchased and the number of matching shares that were allocated for nil consideration.

 

Director/PDMR	Number of partnership shares purchased	Number. of matching shares allocated
G C McGrath	31	7

 

 

The Notification of Dealing Form can be found below.

 

This announcement is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

Lydia Harratt

Group Company Secretary

Zotefoams plc

020 8664 1600

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology, delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA, Stilling, Denmark (microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

 

 

DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name: Gary Christopher McGrath
2.	Reason for the notification
a)	Position/status: Group CFO
b)	Initial notification/Amendment: Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name:   Zotefoams plc
b)	LEI: 213800B6P256B5XN8D32
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605
b)	Nature of the transaction: Award of matching shares under the Share Incentive Plan
c)	Price(s) and volume(s): Price(s) Volume(s) £0.00 7
d)	Aggregated information: n/a - single transaction
e)	Date of the transaction: 12 August 2024
f)	Place of the transaction: XLON
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605
b)	Nature of the transaction: Purchase of partnership shares under the Share Incentive Plan
c)	Price(s) and volume(s): Price(s) Volume(s) £4.8878 31
d)	Aggregated information: n/a - single transaction
e)	Date of the transaction: 12 August 2024
f)	Place of the transaction: XLON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHPJMFTMTMBBII